Frontlight ResearchEarly access
Lung cancer trials in United States
900 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleLongitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer
- Where
- New York
- Age
- 18 years to 100 years
- People
- 48
- Run by
- NYU Langone Health
See details and how to joinNCT04063501 - Phase 2Taking peopleA Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
- Where
- Baltimore, Boca Raton, Boston, Charlotte, Cleveland, East Syracuse, Everett, Fairfax, Hackensack, La Jolla, Mayfield Heights, Miami Beach, New Brunswick, Orange, Orlando, Salt Lake City, Seattle, Stanford, St Louis, Tampa, Warrensville Heights, Washington D.C., Westwood, Winston-Salem
- Age
- 18 years and over
- People
- 520 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05498428 · EU 2023-505065-91-00 - Phase 1Taking peoplePhase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Where
- Canton, Charlotte, Dallas, Detroit, Durham, Fairfax, St Louis, West Valley City
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Sairopa B.V.
See details and how to joinNCT05856981 - Phase 1/2Taking peopleSafety and Efficacy of OBX-115 in Advanced Solid Tumors
- Where
- Columbus, Houston, Los Angeles, Louisville, Miami, New York, Orlando, Pittsburgh, Stanford, Tampa, Tucson
- Age
- 18 years and over
- People
- 254 worldwide
- Run by
- Obsidian Therapeutics, Inc.
See details and how to joinNCT06060613 - Phase 3Taking peopleSacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
- Where
- Burbank, Cleveland, Corvallis, Grand Junction, Hattiesburg, Houston, Jacksonville, Louisville, Marietta, Minneapolis, Phoenix, Reno, Rochester, Westbrook, Worcester
- Age
- 18 years and over
- People
- 614 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06170788 · EU 2023-503376-24-00 - Phase 1/2Taking peopleFiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Where
- Atlanta, Birmingham, Boston, Cincinnati, Columbus, East Brunswick, Fairfax, Fort Worth, Irving, Medford, New York, Oklahoma City, West Valley City
- Age
- 18 years and over
- People
- 334 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06303505 · EU 2024-511074-80-01 - Phase 2Taking peopleA Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Where
- Albuquerque, Ames, Ann Arbor, Athens, Atlanta, Austin, Baltimore, Boca Raton, Boston, Bryn Mawr, Cerritos, Charleston, Charlotte, Chattanooga, Chicago, Cincinnati, Corona, Dallas, Daphne, Decatur, Denver, Duarte, Durham, East Syracuse, El Paso, Eugene, Fairfax, Fairway, Flemington, Fort Lauderdale, Fort Myers, Fort Wayne, Fort Worth, Gainesville, Glendale, Golden, Goodyear, Greenbrae, Hinsdale, Hollywood, Houston, Huntington Beach, Huntsville, Irvine, Jackson, Jacksonville, Kansas City, Knoxville, La Jolla, Lancaster, Lebanon, Lone Tree, Long Beach, Los Alamitos, Los Angeles, Memphis, Miami, Mineola, Minneapolis, Mission Viejo, Morristown, Murrieta, Nashville, Newark, New Brunswick, New Haven, Newnan, New York, Niles, Noblesville, Oakland, Odessa, Olympia, Orange, Orlando, Palo Alto, Paoli, Pembroke Pines, Peoria, Philadelphia, Portland, Rochester, Roseville, Sacramento, Salt Lake City, San Antonio, San Francisco, Santa Barbara, Santa Clara, Santa Rosa, Schenectady, Shirley, Silver Spring, Sioux Falls, South Pasadena, Spokane, Spring, Springfield, St Louis, St. Petersburg, Summit, Tampa, Teaneck, The Bronx, The Woodlands, Tyler, Upland, Vallejo, Vancouver, Walnut Creek, Washington D.C., Webster, Westbury, West Palm Beach, West Reading, Wilson, Winston-Salem, Wynnewood, Ypsilanti, Zion
- Age
- 18 years and over
- People
- 480 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06667076 · EU 2025-520730-28-00 - Phase 2Taking peopleA Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
- Where
- Atlanta, Boston, Burlington, Chapel Hill, Cleveland, Farmington, Houston, La Jolla, Miami, New Brunswick, New Haven, New York, Orlando, Philadelphia, Pinehurst, Portland, St Louis
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- Johnson & Johnson Enterprise Innovation Inc.
See details and how to joinNCT06667908 · EU 2024-518276-32-00 - Phase 1Taking peopleA Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Where
- Boston, Cleveland, Denver, Fairfax, Grand Rapids, Jacksonville, Oklahoma City, Philadelphia, Phoenix, Rochester, San Antonio
- Age
- 18 years and over
- People
- 140
- Run by
- Kumquat Biosciences Inc.
See details and how to joinNCT06720987 - No phaseTaking peoplePILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
- Where
- Galveston, Salt Lake City
- Age
- 18 years and over
- People
- 20
- Run by
- University of Utah
See details and how to joinNCT06945484 - Phase 1/2Taking peopleA Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer
- Where
- Fairfax, New York
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07227025 - Phase 2Taking peopleStudy to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
- Where
- Albany, Atlanta, Billings, Chapel Hill, Dallas, East Brunswick, Eugene, Fairfax, Fountain Valley, Irvine, Lincoln, Miami, Nashville, Portland, San Diego, Santa Rosa, Tampa, The Bronx, Washington D.C., West Haven-Sylvan
- Age
- 18 years and over
- People
- 240 worldwide
- Run by
- Genmab
See details and how to joinNCT07288177 · EU 2025-522107-18-00 - Phase 2Taking peopleA Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
- Where
- Ann Arbor, Ashland, Aventura, Basking Ridge, Bath, Beaver, Bemidji, Bismarck, Bloomington, Brainerd, Brighton, Brunswick, Canton, Cape Girardeau, Carlisle, Carthage, Chapel Hill, Charleston, Chelsea, Chicago, Clackamas, Collierville, Columbus, Commack, Decatur, Deer River, Duluth, Durham, Eau Claire, Erie, Eureka, Fargo, Farmington, Farrell, Galesburg, Greensburg, Harrisburg, Harrison, Hayward, Hibbing, Indiana, Jacksonville, Jonesboro, Kalamazoo, Kewanee, Livonia, Los Angeles, Macomb, Marshfield, Mechanicsburg, Memphis, Miami Beach, Middletown, Monroeville, Montvale, Newberg, New Castle, New York, N. Huntingdon, O'Fallon, Oregon City, Oswego, Ottawa, Oxford, Parker, Pekin, Peoria, Peru, Pittsburgh, Portland, Princeton, Rice Lake, Sainte Genevieve, Sandstone, Sanford, Scarborough, Seneca, Sioux Falls, Southhaven, South Portland, Spooner, Stevens Point, St Louis, Sullivan, Superior, Syracuse, The Bronx, Traverse City, Uniondale, Verona, Virginia, Washington, Weston, Wichita, Ypsilanti
- Age
- 18 years and over
- People
- 164
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT07293247 - Phase 2/3Taking peopleA Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
- Where
- Albuquerque, Blacksburg, Daphne, Doral, Fairfax, Fort Worth, Glendale, Mineola, Nashville, New York, Orange, Peoria, Plantation, Pueblo, Tamarac, The Bronx, White Plains, Winchester
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07365319 · EU 2025-525013-23-00 - Phase 1Taking peopleA Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
- Where
- Austin, Boston, Cleveland, Dallas, Detroit, Fairfax, Hackensack, Los Angeles, Nashville, New York, Philadelphia, Portland, Salt Lake City, San Antonio
- Age
- 18 years and over
- People
- 48
- Run by
- Kumquat Biosciences Inc.
See details and how to joinNCT07542704 - Phase 1Taking peopleA Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Where
- Boston, Houston, Irving, New Haven, Sarasota
- Age
- 18 years and over
- People
- 200
- Run by
- Immunome, Inc.
See details and how to joinNCT07578571 - Phase 2Taking peopleA Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
- Where
- Duarte, Fairfax, Irvine, Portland, Stanford
- Age
- 18 years and over
- People
- 68 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07586202 - No phaseTaking peopleAn Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
- Where
- Seattle
- Age
- 50 years to 80 years
- People
- 60
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07615764 - Phase 1/2Taking peopleA Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
- Where
- Los Angeles, Scottsdale
- Age
- 18 years to 75 years
- People
- 111
- Run by
- VM Discovery, Inc.
See details and how to joinNCT07636785 - Phase 1Taking peopleStudy of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
- Where
- New York, Omaha
- Age
- 18 years and over
- People
- 156 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07660055 - Phase 1Taking peopleA Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.
- Where
- Grand Rapids, Nashville, San Antonio
- Age
- 18 years and over
- People
- 280
- Run by
- Pfizer
See details and how to joinNCT07903415 · EU 2026-527660-32-00 - Phase 2Taking peopleA Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
- Where
- Athens, Des Moines, Fairfax, Glendale, Houston, La Jolla, Louisville, New Hyde Park, New York, Tampa
- Age
- 18 years and over
- People
- 66 worldwide
- Run by
- Teligene US
See details and how to joinNCT06010329 - Phase 2/3Taking peopleSafety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
- Where
- Anchorage, Birmingham, Canton, Cedar Rapids, Cincinnati, Clermont, Cleveland, Columbia, Concord, Coral Springs, Dayton, East Brunswick, Elizabethtown, Fairfax, Fenton, Florham Park, Fort Wayne, Frederick, Hastings, Hendersonville, Houston, Indianapolis, Iowa City, Jacksonville, Kettering, Knoxville, La Crosse, La Jolla, Lexington, Marietta, Mayfield Heights, Memphis, Morgantown, Nashville, Oklahoma City, Orange City, Paramus, Poughkeepsie, Richmond, Salt Lake City, Stony Brook, Stuart, Tampa, Vail, Washington D.C., Weston, White Plains, Winchester
- Age
- 18 years and over
- People
- 1,580 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06712316 · EU 2024-515764-31-00 - Phase 3Taking peopleClinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
- Where
- Atlanta, Charleston, Cincinnati, Cleveland, El Segundo, Fairfax, Fort Lauderdale, Fort Myers, Fountain Valley, Fullerton, Glendale, Hickory, Honolulu, Hot Springs, Indianapolis, Irvine, Los Alamitos, Louisville, Miami, Nashville, New Albany, Newport Beach, Richmond, Shenandoah, Spokane, Springdale, Springfield, St Louis, Tampa
- Age
- 18 years to 90 years
- People
- 507 worldwide
- Run by
- ImmunityBio, Inc.
See details and how to joinNCT06745908 · EU 2025-521221-32-00 - Phase 1Taking peopleA Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 24
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06807632